TMDX (STOCKS)
TransMedics Group, Inc. Common Stock
$114.150000
+0.150000 (+0.13%)
Prev close: $114.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Waleed H. Hassanein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,890.93M
- Employees
- 728
- P/E (TTM)
- 23.39
- P/B (TTM)
- 8.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
9
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.53 | $0.40 | +0.1313 | +32.93% |
|
Sep 2025 (Q3)
|
$0.66 | $0.36 | +0.3021 | +84.41% |
|
Jun 2025 (Q2)
|
$0.92 | $0.46 | +0.4601 | +100.04% |
|
Mar 2025 (Q1)
|
$0.70 | $0.26 | +0.4382 | +167.38% |
Financial Statements
| Revenues | $605.49M |
| Benefits Costs and Expenses | $497.97M |
| Cost Of Revenue | $242.69M |
| Costs And Expenses | $497.97M |
| Gross Profit | $362.81M |
| Nonoperating Income/Loss | -$1.06M |
| Operating Expenses | $254.22M |
| Selling, General, and Administrative Expenses | $185.17M |
| Research and Development | $69.06M |
| Operating Income/Loss | $108.58M |
| Income/Loss From Continuing Operations After Tax | $190.29M |
| Income/Loss From Continuing Operations Before Tax | $107.52M |
| Income Tax Expense/Benefit | -$82.77M |
| Income Tax Expense/Benefit, Deferred | -$83.54M |
| Net Income/Loss | $190.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $190.29M |
| Net Income/Loss Available To Common Stockholders, Basic | $190.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.60 |
| Diluted Earnings Per Share | $4.87 |
| Basic Average Shares | 33,993,468 |
| Diluted Average Shares | 40,540,694 |
| Common Stock Dividends | $0.00 |
| Assets | $1.07B |
| Current Assets | $637.78M |
| Inventory | $48.88M |
| Other Current Assets | $588.90M |
| Noncurrent Assets | $430.59M |
| Fixed Assets | $327.66M |
| Intangible Assets | $1.95M |
| Other Non-current Assets | $100.99M |
| Liabilities | $595.27M |
| Current Liabilities | $89.31M |
| Accounts Payable | $10.35M |
| Wages | $28.44M |
| Other Current Liabilities | $50.51M |
| Noncurrent Liabilities | $505.97M |
| Equity | $473.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $473.10M |
| Liabilities And Equity | $1.07B |
| Net Cash Flow From Operating Activities | $192.84M |
| Net Cash Flow From Operating Activities, Continuing | $192.84M |
| Net Cash Flow From Investing Activities | -$59.25M |
| Net Cash Flow From Investing Activities, Continuing | -$59.25M |
| Net Cash Flow From Financing Activities | $16.86M |
| Net Cash Flow From Financing Activities, Continuing | $16.86M |
| Exchange Gains/Losses | $1.27M |
| Net Cash Flow | $151.72M |
| Net Cash Flow, Continuing | $150.45M |
| Comprehensive Income/Loss | $190.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $190.78M |
| Other Comprehensive Income/Loss | $488.00K |